The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• NOTCH1 signaling is crucial in T cell acute lymphoblastic leukemia (T-ALL) pathogenesis.
• Identifying NOTCH1 downstream targets is vital for understanding T-ALL initiation and relapse.
• Leukemia-initiating cell (LIC) activity is a key therapeutic target in T-ALL.

Purpose of the Study:

• To elucidate NOTCH1 downstream signals and target genes in T-ALL pathogenesis.
• To establish a preclinical model for studying T-ALL development and relapse.
• To investigate the role of CD44 in T-ALL and its therapeutic potential.

Main Methods:

• Generation of a human T-ALL xenograft model in immunodeficient mice by ectopic expression of active NOTCH1.
• Identification of direct NOTCH1 transcriptional targets using the established T-ALL model.
• Assessment of CD44 expression as an early hallmark of preleukemic cells.
• Evaluation of CD44's role in bone marrow (BM) niche interactions and LIC activity.
• Therapeutic efficacy testing of anti-CD44 antibody treatment in xenotransplanted mice.

Main Results:

• A human T-ALL model recapitulating patient disease was successfully generated in vivo.
• CD44 was identified as a direct NOTCH1 transcriptional target.
• CD44 overexpression was observed as an early marker in preleukemic cells and T-ALL progression.
• CD44 was found to be essential for LIC activity and disease progression by supporting BM niche interactions.
• Anti-CD44 antibody treatment demonstrated therapeutic benefits in preclinical models.

Conclusions:

• The NOTCH1/CD44 axis plays a critical role in T-ALL pathogenesis and LIC activity.
• CD44 is a significant downstream effector of NOTCH1 signaling in T-ALL.
• Targeting CD44 presents a promising therapeutic strategy to combat T-ALL relapse.